Vincerx Pharma (VINC) Earnings Date, Estimates & Call Transcripts → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free VINC Stock Alerts $0.80 -0.05 (-5.87%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 13EstimatedActual EPS (Mar. 29) -$0.23 Missed By -$0.23 Get Vincerx Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for VINC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVINC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VINC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Vincerx Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.26)($0.26)($0.26)Q2 20241($0.27)($0.27)($0.27)Q3 20241($0.34)($0.34)($0.34)Q4 20241($0.42)($0.42)($0.42)FY 20244($1.29)($1.29)($1.29)VINC Earnings Date and InformationVincerx Pharma last released its earnings results on March 29th, 2024. The reported ($0.23) earnings per share (EPS) for the quarter. Vincerx Pharma has generated ($1.89) earnings per share over the last year (($1.89) diluted earnings per share). Earnings for Vincerx Pharma are expected to decrease in the coming year, from ($0.97) to ($1.11) per share. Vincerx Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.Read More Vincerx Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/13/2024Estimated)------- 3/29/2024Q4 2023-($0.23)($0.23)($0.23)--11/14/2023Q3 2023($0.49)($0.46)+$0.03($0.46)--8/7/2023Q2 2023($0.65)($0.52)+$0.13($0.52)--5/11/2023Q1 2023($0.69)($0.68)+$0.01($0.68)--3/28/2023Q4 2022($0.63)($0.65)($0.02)($0.65)--11/10/2022Q3 2022($0.80)($0.80)-($0.80)-- Get the Latest News and Ratings for VINC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.92)($0.88)+$0.04($0.88)--5/12/2022Q1 2022($0.87)($0.79)+$0.08($0.79)--3/29/2022Q4 2021($0.93)($0.85)+$0.08($1.39)--11/12/2021Q3 2021($0.79)($1.02)($0.23)($0.65)--8/12/2021Q2 2021($0.30)($0.12)+$0.18($0.12)--5/16/2021Q1 2021($0.32)($0.46)($0.14)($0.46)-- Vincerx Pharma Earnings - Frequently Asked Questions When is Vincerx Pharma's earnings date? Vincerx Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on VINC's earnings history. How much profit does Vincerx Pharma generate each year? Vincerx Pharma (NASDAQ:VINC) has a recorded net income of -$40.16 million. VINC has generated -$1.89 earnings per share over the last four quarters. What is Vincerx Pharma's EPS forecast for next year? Vincerx Pharma's earnings are expected to decrease from ($0.97) per share to ($1.11) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Avalo Therapeutics Earnings Results Talphera Earnings Results Orgenesis Earnings Results NeuroSense Therapeutics Earnings Results Indaptus Therapeutics Earnings Results Galecto Earnings Results Minerva Neurosciences Earnings Results VBI Vaccines Earnings Results NeuroBo Pharmaceuticals Earnings Results Cocrystal Pharma Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:VINC) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking: One AI startup's revenue could surge 4,735%Manward PressElon to Transform U.S. Economy? Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin Analytics[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.